BloodCenter of Wisconsin
Bonnie Dittel, Ph.D.
“Regulation of EAE by CD86 expressed within the CNS” Investigating how an immune system signaling molecule suppresses MS-like disease for clues to new treatments to stop MS disease activity.
Medical College of Wisconsin
Hao Zhang, Ph.D.
Funding: $ 646,763
“Therapeutic implications of KYC, a novel myeloperoxidase inhibitor, in multiple sclerosis” Can blocking free radicals in an MS model provide clues to stopping disease progression in people with MS?
University of Wisconsin-Madison
Shing-yan Chiu, Ph.D.
Funding: $ 612,977
“A Novel Specific Treatment for Progressive MS: Elimination of Mitochondrial Anchoring” Researchers are studying mouse models with features similar to progressive MS to investigate possible new approaches to stopping MS progression.
Aaron Field, M.D., Ph.D.
“Study of CCSVI in MS using quantitative time-resolved 3D MRV” Understanding the role of CCSVI (vein blockage) in MS and identifying optimal methods for screening for the condition.
Colleen Hayes, Ph.D.
Funding: $ 585,146
“Vitamin D and estrogen synergy in the control of EAE” Exploring how vitamin D and the sex hormone estrogen may interact to control MS-like immune attacks and its implications for MS.